Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
Quick Stats
Jan 30, 202652.4
AI Score
HOLD0.71
Volume Ratio
Mar 18, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
LRMR Stock Summary
Last updated Jan 30, 2026
LRMR is currently trading at $3.54, positioned above its 200-day moving average of $3.41, indicating a long-term uptrend. The stock has a 52-week range of $1.61 to $5.37.
Technical Analysis: The 50-day moving average stands at $3.59, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 50.159, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.012, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates LRMR at 52.4/100 with a HOLD recommendation.
LRMR (Larimar Therapeutics, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 50.159 |
| CMF (20) | 0.012 |
| ROC (10) | 8.589 |
| ADX (14) | 14.729 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.011 |
| AROONOSC (14) | 42.857 |
| WILLAMS %R (14) | -30.986 |
| MFI (14) | 49.484 |
LRMR Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
LRMR Price vs Max Options Open Interest
LRMR Max Change In Options Open Interest
LRMR Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LRMR Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LRMR Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LRMR Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Larimar Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
LRMR Moving Averages Analysis
Larimar Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
LRMR (Larimar Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 3.48 |
| 20 | 3.42 |
| 30 | 3.54 |
| 50 | 3.59 |
| 100 | 3.84 |
| 200 | 3.41 |
LRMR Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 303.0 million |
| Earnings/Share ($) | -1.96 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -2.0418 |
| EPS Estimate Next Year ($) | -1.8188 |
| WallStreet Target Price ($) | 14.6667 |
| Most Recent Quarter |